Abstract
Postoperative adjuvant hormone therapy and hormone therapy in disseminated breast cancer will be discussed systematically. The classical ablative and additive endocrine therapeutic measures--with the exception of ovarectomy and gestagen therapy--are increasingly being replaced by antagonists. Individual chapters discuss recent experience with combined hormone-radiotherapy or hormone-chemotherapy. In addition, a successful therapy scheme for the treatment of disseminated breast cancer will be presented.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Adrenalectomy
-
Aminoglutethimide / therapeutic use
-
Androgens / therapeutic use
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / therapy*
-
Castration
-
Cyproterone / therapeutic use
-
Estrogens / therapeutic use
-
Female
-
Gonadotropins / antagonists & inhibitors
-
Hormones / therapeutic use*
-
Humans
-
Hydrocortisone / therapeutic use
-
Hypophysectomy
-
Menopause
-
Neoplasm Metastasis
-
Progesterone / therapeutic use
-
Tamoxifen / therapeutic use
Substances
-
Adrenal Cortex Hormones
-
Androgens
-
Estrogens
-
Gonadotropins
-
Hormones
-
Tamoxifen
-
Aminoglutethimide
-
Progesterone
-
Cyproterone
-
Hydrocortisone